Qualitest Pharmaceuticals has received approval from the Food and Drug Administration to market acetaminophen and codeine phosphate oral solution, 120mg/12mg per 5ml.


Qualitest Pharmaceuticals, acetaminophen and codeine phosphate oral solution, pain reliever, generic drug, mild to moderate pain, pharmaceuticals, Food and Drug Administration, FDA












































































































































































































































INSIDE THIS ISSUE
News
Opinion
Other Services
Reprints / E-Prints
Submit News
White Papers

Supplier News Breaks Archives

Qualitest gets FDA OK for pain reliever

November 14th, 2011

HUNTSVILLE, Ala. – Qualitest Pharmaceuticals has received approval from the Food and Drug Administration to market acetaminophen and codeine phosphate oral solution, 120mg/12mg per 5ml.

The generic drug manufacturer said Monday that sales for acetaminophen and codeine phosphate oral solution in the United States totaled $4.3 million for the 12 months ended Sept. 30, based on data from IMS Health.

Acetaminophen and codeine phosphate oral solution is indicated for the relief of mild to moderate pain.

 

Advertisement